Hydralazine
Apresoline (hydralazine) is a small molecule pharmaceutical. Hydralazine was first approved as Apresoline on 1982-01-01. It is used to treat heart failure, malignant hypertension, and pulmonary hypertension in the USA.
| Trade Name | Apresoline |
|---|---|
| Common Name | Hydralazine |
| Indication | heart failure, malignant hypertension, pulmonary hypertension |
| Drug Class | Antihypertensives (hydrazine-phthalazines) |
